Combi-TED: a new trial testing Tedopi R with docetaxel or nivolumab in metastatic non-small-cell lung cancer progressing after first line study protocol

The study is funded by Fondazione Ricerca Traslazionale (FoRT). G Pasello is an Advisor/Consultant for AstraZeneca, Lilly, MSD, Roche, Takeda and Novartis. He received unconditioned research support from AstraZeneca and Roche. The other authors have no conflicts of interest to declare. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.